US FTC general counsel stays in-house insulin pricing suit against PBMs
MLex Summary: The general counsel of the US Federal Trade Commission has ordered that an in-house administrative antitrust lawsuit the agency brought against three largest pharmacy benefit managers be stayed. Lucas...To view the full article, register now.
Already a subscriber? Click here to view full article